Results 241 to 250 of about 31,457 (263)

Efficacy and safety of mepolizumab in a real-world cohort of patients with severe eosinophilic asthma

Journal of Asthma, 2021
Barak Pertzov, Dorit Shitenberg, Osnat Shtraichman   +2 more
exaly  

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

New England Journal of Medicine, 2014
Guy Brusselle, Alfredo Chetta, Hector Ortega   +2 more
exaly  

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Lancet, The, 2012
Hector Ortega, Ian Pavord, Eugene Bleecker   +2 more
exaly  

Non-eosinophilic cor ticosteroid unresponsive asthma

Lancet, The, 1999
Andrew Wardlaw, Ian Pavord, Sarah Diver   +2 more
exaly  

Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study

Clinical Therapeutics, 2019
Robert Price, Guy Brusselle, Frank Albers   +2 more
exaly  

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis

Journal of Allergy and Clinical Immunology, 2004
Andrew Wardlaw, Peter Bradding, Ian Pavord   +2 more
exaly  

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma

Journal of Allergy and Clinical Immunology, 2017
Pranabashis Haldar, Hector Ortega, Ian Pavord   +2 more
exaly  

Characteristics of eosinophilic and non-eosinophilic asthma during treatment with inhaled corticosteroids

Journal of Asthma, 2015
Ichiei Narita, Yosuke Kimura
exaly  

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis

Journal of Allergy and Clinical Immunology, 2002
Andrew Wardlaw, Peter Bradding, Ian Pavord   +2 more
exaly  

Role of Eosinophils in Asthma, and the Relationship with Eosinophilic Sinusitis, Esophagitis and Asthma

Nihon Kikan Shokudoka Gakkai Kaiho, 2018
T. Iwanaga, Y. Tohda
openaire   +1 more source